Evidence map›Paper›PMID 40785686›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2025

Genetic analysis of

Yingying Zhang, Nannan Li, Min Lu, Yumeng Lei, Kaiqian Zhang, Jishi Liu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yingying ZhangDepartment of Nephropathy and Rheumatology, Third Xiangya Hospital, Central South University, Changsha 410013. 228311021@csu.edu.cn.
Nannan LiDepartment of Nephropathy and Rheumatology, Third Xiangya Hospital, Central South University, Changsha 410013.
Min LuDepartment of Nephropathy and Rheumatology, Third Xiangya Hospital, Central South University, Changsha 410013.
Yumeng LeiDepartment of Nephropathy and Rheumatology, Third Xiangya Hospital, Central South University, Changsha 410013.
Kaiqian ZhangDepartment of Nephropathy and Rheumatology, Third Xiangya Hospital, Central South University, Changsha 410013.
Jishi LiuDepartment of Nephropathy and Rheumatology, Third Xiangya Hospital, Central South University, Changsha 410013. 26545559@qq.com.

Funding

the Excellent Youth Foundation of Hunan Scientific Committee 2025JJ20085the Traditional Chinese Medicine Research Project of Hunan Province B2024118
6 · The paper itself

Abstract

Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare autosomal dominant hereditary disorder characterized by hyperuricemia, gout, impaired urinary concentration, and progressive renal failure. It is primarily caused by mutations in uromodulin (

Indexed as

MutationMutation, MissenseNephritis, InterstitialUromodulinAdultExome SequencingHumansMalePedigreeUMOD protein, humanUromodulinautosomal dominant tubulointerstitial kidney diseasegenetic analysismissense mutationUMOD genewhole-exome sequencing

Identifiers

PMID40785686
PMCPMC12329733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.